{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:25:59Z","timestamp":1784035559793,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese National Key Technology R&D Program, Ministry of Science and Technology","award":["2021YFC2501300"],"award-info":[{"award-number":["2021YFC2501300"]}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science & Technology Commission","doi-asserted-by":"crossref","award":["No.Z201100005520022,23, 25-27"],"award-info":[{"award-number":["No.Z201100005520022,23, 25-27"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82241019"],"award-info":[{"award-number":["82241019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271855"],"award-info":[{"award-number":["82271855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900054"],"award-info":[{"award-number":["81900054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-013, C-002, D-009"],"award-info":[{"award-number":["2022-PUMCH-B-013, C-002, D-009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pulmonary arterial hypertension is a major cause of death in systemic lupus erythematosus, but there are no tools specialized for predicting survival in systemic lupus erythematosus-associated pulmonary arterial hypertension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Research question<\/jats:title><jats:p>To develop a practical model for predicting long-term prognosis in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prognostic model was developed from a multicenter, longitudinal national cohort of consecutively evaluated patients with systemic lupus erythematosus-associated pulmonary arterial hypertension. The study was conducted between November 2006 and February 2020. All-cause death was defined as the endpoint. Cox regression and least absolute shrinkage and selection operators were used to fit the model. Internal validation of the model was assessed by discrimination and calibration using bootstrapping.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 310 patients included in the study, 81 (26.1%) died within a median follow-up of 5.94\u00a0years (interquartile range 4.67\u20137.46). The final prognostic model included eight variables: modified World Health Organization functional class, 6-min walking distance, pulmonary vascular resistance, estimated glomerular filtration rate, thrombocytopenia, mild interstitial lung disease, N-terminal pro-brain natriuretic peptide\/brain natriuretic peptide level, and direct bilirubin level. A 5-year death probability predictive algorithm was established and validated using the C-index (0.77) and a satisfactory calibration curve. Risk stratification was performed based on the predicted probability to improve clinical decision-making.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This new risk stratification model for systemic lupus erythematosus-associated pulmonary arterial hypertension may provide individualized prognostic probability using readily obtained clinical risk factors. External validation is required to demonstrate the accuracy of this model's predictions in diverse patient populations.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12931-023-02522-2","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T05:01:38Z","timestamp":1694235698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jingge","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wufang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieruo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"issue":"1","key":"2522_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10067-013-2383-3","volume":"33","author":"Y Fei","year":"2014","unstructured":"Fei Y, Shi X, Gan F, Li X, Zhang W, Li M, Hou Y, Zhang X, Zhao Y, Zeng X, Zhang F. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014;33(1):57\u201363.","journal-title":"Clin Rheumatol"},{"key":"2522_CR2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2017.11.020","volume":"134","author":"IS Bazan","year":"2018","unstructured":"Bazan IS, Mensah KA, Rudkovskaia AA, Adonteng-Boateng PK, Herzog EL, Buckley L, Fares WH. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: a review. Respir Med. 2018;134:42\u20136.","journal-title":"Respir Med"},{"key":"2522_CR3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","volume":"236","author":"J Zhao","year":"2017","unstructured":"Zhao J, Wang Q, Liu Y, Tian Z, Guo X, Wang H, Lai J, Huang C, Yang X, Li M, Zeng X. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China. Int J Cardiol. 2017;236:432\u20137.","journal-title":"Int J Cardiol"},{"issue":"4","key":"2522_CR4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1183\/09031936.00090814","volume":"44","author":"L Chung","year":"2014","unstructured":"Chung L, Kawut SM. Connective tissue disease-associated pulmonary arterial hypertension: \u201cBeijing style.\u201d Eur Respir J. 2014;44(4):839\u201341.","journal-title":"Eur Respir J"},{"issue":"4","key":"2522_CR5","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2016;46(4):903\u201375.","journal-title":"Eur Respir J"},{"issue":"38","key":"2522_CR6","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"2","key":"2522_CR7","doi-asserted-by":"crossref","first-page":"1700740","DOI":"10.1183\/13993003.00740-2017","volume":"50","author":"MM Hoeper","year":"2017","unstructured":"Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Gr\u00fcnig E. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J. 2017;50(2):1700740.","journal-title":"Eur Respir J"},{"issue":"2","key":"2522_CR8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","volume":"122","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Ya\u00efci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Ja\u00efs X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122(2):156\u201363.","journal-title":"Circulation"},{"issue":"47","key":"2522_CR9","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","volume":"39","author":"D Kylhammar","year":"2018","unstructured":"Kylhammar D, Kjellstr\u00f6m B, Hjalmarsson C, Jansson K, Nisell M, S\u00f6derberg S, Wikstr\u00f6m G, R\u00e5degran G. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J. 2018;39(47):4175\u201381.","journal-title":"Eur Heart J"},{"issue":"2","key":"2522_CR10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","volume":"122","author":"RL Benza","year":"2010","unstructured":"Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122(2):164\u201372.","journal-title":"Circulation"},{"key":"2522_CR11","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/854941","volume":"2012","author":"A Dhala","year":"2012","unstructured":"Dhala A. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction. Clin Dev Immunol. 2012;2012: 854941.","journal-title":"Clin Dev Immunol"},{"issue":"11","key":"2522_CR12","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/0961203313499086","volume":"22","author":"M Li","year":"2013","unstructured":"Li M, Zhang W, Leng X, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Zhang F, Zhao Y, Zeng X, CSTAR co-authors. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus. 2013;22(11):1192\u20139.","journal-title":"Lupus"},{"issue":"8","key":"2522_CR13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10067-015-3003-1","volume":"34","author":"M Li","year":"2015","unstructured":"Li M, Tian X, Zhang W, Leng X, Zeng X. CRDC: a Chinese rheumatology research platform. Clin Rheumatol. 2015;34(8):1347\u201352.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"2522_CR14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0961203314527366","volume":"23","author":"M Li","year":"2014","unstructured":"Li M, Wang Q, Zhao J, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Tian Z, Liu Y, He J, Zhang F, Zhao Y, Zeng X, CSTAR co-authors. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus. 2014;23(10):1085\u201391.","journal-title":"Lupus"},{"issue":"2","key":"2522_CR15","doi-asserted-by":"crossref","first-page":"1800081","DOI":"10.1183\/13993003.00081-2018","volume":"53","author":"J Qian","year":"2019","unstructured":"Qian J, Li M, Zhang X, Wang Q, Zhao J, Tian Z, Wei W, Zuo X, Zhang M, Zhu P, Ye S, Zhang W, Zheng Y, Qi W, Li Y, Zhang Z, Ding F, Gu J, Liu Y, Wang Y, Zeng X, following investigators were collaborators in the CSTAR-PAH study. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J. 2019;53(2):1800081.","journal-title":"Eur Respir J."},{"key":"2522_CR16","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350: g7594.","journal-title":"BMJ"},{"issue":"8","key":"2522_CR17","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677\u201386.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2522_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-019-0950-y","volume":"21","author":"M Kanwar","year":"2019","unstructured":"Kanwar M, Raina A, Lohmueller L, Kraisangka J, Benza R. The use of risk assessment tools and prognostic scores in managing patients with pulmonary arterial hypertension. Curr Hypertens Rep. 2019;21(6):45.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"2522_CR19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.autrev.2015.11.012","volume":"15","author":"J Qian","year":"2016","unstructured":"Qian J, Wang Y, Huang C, Yang X, Zhao J, Wang Q, Tian Z, Li M, Zeng X. Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: a PRISMA-compliant systematic review and meta-analysis. Autoimmun Rev. 2016;15(3):250\u20137.","journal-title":"Autoimmun Rev"},{"key":"2522_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jclinepi.2017.11.013","volume":"98","author":"EW Steyerberg","year":"2018","unstructured":"Steyerberg EW, Ioannidis JPA, van Calster B, Collaborators. Poor performance of clinical prediction models: the harm of commonly applied methods. J Clin Epidemiol. 2018;98:133\u201343.","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"2522_CR21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17(4):343\u20136.","journal-title":"Control Clin Trials"},{"issue":"6","key":"2522_CR22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","volume":"18","author":"S van Buuren","year":"1999","unstructured":"van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18(6):681\u201394.","journal-title":"Stat Med"},{"issue":"4","key":"2522_CR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"key":"2522_CR24","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"2004","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley Classics Library; 2004."},{"issue":"4","key":"2522_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395.","journal-title":"Stat Med"},{"key":"2522_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"D Cox","year":"1972","unstructured":"Cox D. Regression models and life tables. J Royal Stat Soc B. 1972;34:187\u2013200.","journal-title":"J Royal Stat Soc B"},{"key":"2522_CR27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Schoenfeld","year":"1982","unstructured":"Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239\u201341.","journal-title":"Biometrika"},{"issue":"8","key":"2522_CR28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54(8):774\u201381.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2522_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med."},{"key":"2522_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","volume":"78","author":"G Brier","year":"1950","unstructured":"Brier G. Verification of forecasts expressed in terms of probability. Mon Weather Rev. 1950;78:1\u20133.","journal-title":"Mon Weather Rev"},{"issue":"14","key":"2522_CR31","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ, McGinn T, Guyatt G. Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA. 2017;318(14):1377\u201384.","journal-title":"JAMA"},{"issue":"1","key":"2522_CR32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, Topic Group \u2018Evaluating diagnostic tests and prediction models\u2019 of the STRATOS initiative. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230.","journal-title":"BMC Med."},{"issue":"2","key":"2522_CR33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1378\/chest.11-0676","volume":"141","author":"RL Benza","year":"2012","unstructured":"Benza RL, Gomberg-Maitland M, Miller DP, Frost A, Frantz RP, Foreman AJ, Badesch DB, McGoon MD. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest. 2012;141(2):354\u201362.","journal-title":"Chest."},{"issue":"1","key":"2522_CR34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1183\/09031936.00004414","volume":"46","author":"O Sitbon","year":"2015","unstructured":"Sitbon O, Benza RL, Badesch DB, Barst RJ, Elliott CG, Gressin V, Lemari\u00e9 JC, Miller DP, Muros-Le Rouzic E, Simonneau G, Frost AE, Farber HW, Humbert M, McGoon MD. Validation of two predictive models for survival in pulmonary arterial hypertension. Eur Respir J. 2015;46(1):152\u201364.","journal-title":"Eur Respir J"},{"issue":"3","key":"2522_CR35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.healun.2012.11.012","volume":"32","author":"R Cogswell","year":"2013","unstructured":"Cogswell R, McGlothlin D, Kobashigawa E, Shaw R, De Marco T. Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertension. J Heart Lung Transplant. 2013;32(3):293\u20138.","journal-title":"J Heart Lung Transplant"},{"key":"2522_CR36","volume":"8","author":"J Qu","year":"2021","unstructured":"Qu J, Li M, Zeng X, Zhang X, Wei W, Zuo X, et al. Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension. Front Med (Lausanne). 2021;8: 618486.","journal-title":"Front Med (Lausanne)"},{"key":"2522_CR37","doi-asserted-by":"crossref","unstructured":"Hoeper MM, Pausch C, Olsson KM, Huscher D, Pittrow D, Grunig E, et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2022;60(1).","DOI":"10.1183\/13993003.02311-2021"},{"issue":"2","key":"2522_CR38","doi-asserted-by":"crossref","first-page":"1700889","DOI":"10.1183\/13993003.00889-2017","volume":"50","author":"A Boucly","year":"2017","unstructured":"Boucly A, Weatherald J, Savale L, Ja\u00efs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017;50(2):1700889.","journal-title":"Eur Respir J"},{"issue":"6","key":"2522_CR39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.healun.2017.10.028","volume":"37","author":"MM Chakinala","year":"2018","unstructured":"Chakinala MM, Coyne DW, Benza RL, Frost AE, McGoon MD, Hartline BK, Frantz RP, Selej M, Zhao C, Mink DR, Farber HW. Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis. J Heart Lung Transplant. 2018;37(6):696\u2013705.","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2522_CR40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.healun.2014.08.020","volume":"34","author":"HW Farber","year":"2015","unstructured":"Farber HW, Miller DP, McGoon MD, Frost AE, Benton WW, Benza RL. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance. J Heart Lung Transplant. 2015;34(3):362\u20138.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"2522_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ejhf.177","volume":"17","author":"G Querejeta Roca","year":"2015","unstructured":"Querejeta Roca G, Campbell P, Claggett B, Vazir A, Quinn D, Solomon SD, Shah AM. Impact of lowering pulmonary vascular resistance on right and left ventricular deformation in pulmonary arterial hypertension. Eur J Heart Fail. 2015;17(1):63\u201373.","journal-title":"Eur J Heart Fail"},{"key":"2522_CR42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2466-10-22","volume":"10","author":"Y Takeda","year":"2010","unstructured":"Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H, Kimura G. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med. 2010;10:22.","journal-title":"BMC Pulm Med"},{"key":"2522_CR43","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijcard.2016.11.036","volume":"228","author":"XQ Xu","year":"2017","unstructured":"Xu XQ, Lv ZC, Liu QQ, Zhao QH, Wu Y, Sun K, Jiang X, Wang L, Peng FH, Jing ZC. Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. Int J Cardiol. 2017;228:895\u20139.","journal-title":"Int J Cardiol"},{"issue":"21","key":"2522_CR44","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/CIRCULATIONAHA.118.039360","volume":"139","author":"KM Chin","year":"2019","unstructured":"Chin KM, Rubin LJ, Channick R, Di Scala L, Gaine S, Gali\u00e8 N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF. Association of N-terminal pro brain natriuretic peptide and long-term outcome in patients with pulmonary arterial hypertension. Circulation. 2019;139(21):2440\u201350.","journal-title":"Circulation."},{"issue":"1","key":"2522_CR45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chest.2018.01.009","volume":"154","author":"RP Frantz","year":"2018","unstructured":"Frantz RP, Farber HW, Badesch DB, Elliott CG, Frost AE, McGoon MD, Zhao C, Mink DR, Selej M, Benza RL. Baseline and serial brain natriuretic peptide level predicts 5-year overall survival in patients with pulmonary arterial hypertension: Data From the REVEAL Registry. Chest. 2018;154(1):126\u201335.","journal-title":"Chest"},{"issue":"9","key":"2522_CR46","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/rheumatology\/kev097","volume":"54","author":"S Kommireddy","year":"2015","unstructured":"Kommireddy S, Bhyravavajhala S, Kurimeti K, Chennareddy S, Kanchinadham S, Rajendra Vara Prasad I, Rajasekhar L. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study. Rheumatology (Oxford). 2015;54(9):1673\u20139.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-023-02522-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T20:19:06Z","timestamp":1730060346000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-023-02522-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2522"],"URL":"https:\/\/doi.org\/10.1186\/s12931-023-02522-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Peking Union Medical College Hospital (JS-2038). Inform consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Since there are no details on individuals reported within the manuscript, the consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}